Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

New inhibitors may reduce gut toxicity from cancer drugs.

Tofacitinib may help regrow hair in alopecia areata patients.

Rituximab can cause skin issues, but baricitinib may help improve them.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Erlotinib can cause nonscarring hair loss and itchy skin.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Zebrafish help understand genetic causes of skin pigment disorders like albinism.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

SM04755 may be an effective topical treatment for psoriasis.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Using special RNA to target a mutant gene fixed hair problems in mice.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

MVP treatment is effective and safe for recurrent breast cancer.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Mitf plays a key role in melanoma progression and is linked to disease stage.